DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Jackisch C, Piccart MJ, Gelber RD. et al.
HERA trial: 10 years follow up of trastuzumab after adjuvant chemotherapy in HER2 positive early breast cancer – Final analysis. SABCS 2015; Abstr. PD5-01.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.